Related Experiment Video
Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Basic Science and Pathogenesis
Joshua Lykins1, Sherika N Johnson1, Katelynn E Krick2
1Indiana University School of Medicine/Stark Neurosciences Research Institute, Indianapolis, IN, USA.
Insights
Matrix metalloproteinase-9 (MMP9) is crucial in hyperhomocysteinemia-induced cerebral small vessel disease (cSVD) inflammation. MMP9 deficiency reduces inflammatory genes and increases macrophage ECM interactions, impacting cSVD pathways.
Area of Science:
- Neuroscience
- Vascular Biology
- Dementia Research
Background:
- Vascular contributions to cognitive impairment and dementia (VCID) are a leading cause of dementia.
- Hyperhomocysteinemia (HHcy)-induced cerebral small vessel disease (cSVD) involves astrocytic end-feet degeneration and matrix metalloproteinase (MMP) upregulation.
- MMPs remodel the basement membrane, promoting growth factor activation and inflammation in cSVD.
Purpose of the Study:
- To investigate the role of MMP9 in HHcy-driven cSVD.
- To analyze gene expression changes in MMP9 knockout (MMP9-/-) mice under HHcy conditions.
Main Methods:
- C57Bl6/J and MMP9-/- mice were fed either a control or a HHcy-inducing diet for 12 weeks.
- Gene expression was analyzed using NanoString panels.
- Immunohistochemistry and Prussian blue staining assessed microhemorrhages, Dp71, AQP4, and GFAP.
Main Results:
- MMP9-/- mice on a control diet showed reduced inflammation-related genes and microglial markers.
- MMP9 deficiency increased macrophage ECM scavenging receptors and PIP3 pathway regulation.
- Under HHcy diet, MMP9-/- mice had altered gene expression compared to wild-type mice, with a non-significant trend toward fewer microbleeds.
Conclusions:
- MMP9 is integral to the inflammatory response in HHcy-induced cSVD.
- MMP9 absence alters inflammatory and macrophage-related gene expression.
- Distinct molecular pathways are highlighted by MMP9's role, warranting further investigation in cSVD.
Background:
Vascular contributions to cognitive impairment and dementia (VCID) represent a major cause of dementia. Hyperhomocysteinemia (HHcy)-driven cerebral small vessel disease (cSVD) leads to the degeneration of astrocytic end-feet and an upregulation of matrix metalloproteinases (MMPs), which remodel the basement membrane, triggering growth factor activation and inflammation. This study explores the role of MMP9 in cSVD using MMP9-/- mice subjected to a HHcy diet.
Method:
Six-month-old C57Bl6/J mice and MMP9-/- mice were placed on a diet deficient in B vitamins and enriched in methionine or a control diet with normal levels of B vitamins and methionine for 12 weeks. The left hemibrain was fixed in PFA while the right brain was dissected for biochemistry. RNA was extracted from the frontal cortex and analyzed using NanoString's Mouse Neuroinflammation and Cardiovascular Disease panels. Microhemorrhage assessment via Prussian blue staining as well as Dp71, AQP4, and GFAP detected by immunohistochemistry were performed on the left hemisphere.
Result:
Gene expression analysis in MMP9-/- mice on a control diet revealed significant reductions in inflammation-related genes (Cd14, Slamf8, Prkcq, Lag3) and lower expression of the microglial marker P2ry12 compared to wild-type mice. Additionally, MMP9-/- mice exhibited increased expression of macrophage extracellular matrix (ECM) scavenging receptors (Cd44, Cd163, Siglec1) and enhanced regulation of the PIP3 signaling pathway across multiple cell types. Under a HHcy diet, wild-type mice showed elevated expression of Cpa3, Reln, and the glial transcription factor EOMES, while MMP9-/- mice demonstrated increased expression of PECAM1, Hira, Myd88, and Pink1. Although MMP9-/- mice displayed a trend toward fewer microbleeds, the difference was not statistically significant.
Conclusion:
Our findings suggest that MMP9 plays a key role in the inflammatory response associated with HHcy-induced cSVD. The absence of MMP9 led to reduced expression of several inflammation-related genes as well as an increase in ECM interacting genes from macrophages, though differences in gene expression profiles between wild-type and MMP9-/- mice highlight distinct molecular pathways. Further studies are needed to fully understand MMP9's role in cSVD progression.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Urinary Tract Infection II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pneumonia II: Pathophysiology
Stages of Infection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

